SANN Share Price Performance
CHF 17.04
3.88 (29.48%)
Price CHF 17.04
Share Pricen/a
Santhera Pharmaceuticals Holding AG Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 22 Fair Values set on narratives written by author
SANN Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Santhera Pharmaceuticals Holding AG Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
- -3.53
- 19.66%
- -63.79%
- -397.7%
About SANN
- Founded
- 2004
- Employees
- 94
- CEO
- WebsiteView website
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia. The company’s lead pipeline candidate includes Vamorolone, which is developed for the treatments of Duchenne muscular dystrophy. Santhera Pharmaceuticals Holding AG was founded in 2004 and is based in Pratteln, Switzerland.
